Sinaflana-quinacrine ointment for naruzhn.prim th 0.025% 10g

$2.13

Sinaflana-quinacrine ointment for naruzhn.prim th 0.025% 10g

Quantity:

SKU: 0285576941 Categories: , , Tags: ,

Description

Composition
Active substance:
100 g of ointment contains: fluocinolone acetonide in terms of 100% substance – 0.025 g ;.
Excipients:
Propylene glycol 4.975 g, 80 g of petrolatum, lanolin 5 g solid paraffin 10 g.
Description:
Ointment from light yellow to yellow.
Product form:
Ointment for external use 0.025%.
10 or 15 g in a tube of aluminum. Each tube together with instructions for use in a stack of cardboard.
Contraindications
Hypersensitivity, cutaneous manifestations of syphilis, tuberculosis, skin, diaper rash, acne rosacea, extensive psoriatic lesions, anogenital pruritus; Skin infections caused by bacteria, viruses, fungi – pyoderma, chicken pox, herpes, actinomycosis, blastomycosis, sporotrichosis, leg sores associated with varicose veins, erosive and ulcerative lesions of the gastrointestinal tract, ulcers and wounds on the applications, the cancer sites skin, nevi, sebaceous cyst, melanoma, hemangioma, xanthoma, sarcoma, pregnancy, lactation, children’s age (up to 2 years).
Carefully
The girls at puberty.
Dosage
0.25 mg / g
Indications
Inflammatory and allergic skin diseases nemikrobnoy etiology: eczema, atopic dermatitis, chronic simple zoster (restricted neurodermatitis), pruritus, psoriasis and other chronic diseases accompanied by skin dryness.
Interaction with other drugs
Compatible with antimicrobial drugs.
Decreases antihypertensive activity, diuretic, antiarrhythmic agents lekarst¬vennyh, potassium preparations.
Diuretic drugs (except potassium-sparing) increase the risk of hypokalemia.
Overdose
Symptoms include itching and burning of the skin at the site of the drug, hyperglycemia, glycosuria, Cushing’s syndrome.
Treatment: symptomatic against the backdrop of a gradual withdrawal of the drug.
pharmachologic effect
Pharmacological group:
Glucocorticosteroids for local use.
Pharmacological properties:
Glucocorticosteroids for external use; inhibits the release of inflammatory mediators. Skin contact occurs warning accumulation of neutrophils boundary, which leads to a decrease in the inflammatory exudate and cytokine production; inhibition of macrophage migration, reduction of infiltration and granulation processes. It has anti-inflammatory and anti-allergic effect.
Pharmacokinetics:
After absorption from the skin binds to plasma proteins in the liver is metabolized to inactive metabolites.
Excreted mainly by the kidneys.
Conditions of supply of pharmacies
Without recipe.
side effects
Burning, itching, steroid acne, stretch marks, dry skin, folliculitis. With prolonged use – skin atrophy, topical hirsutism, hypertrichosis, telangiectasia, purpura, pigmentation disorders of the skin, alopecia, especially in women, secondary immunodeficiency (exacerbation of chronic infectious diseases, generalization of infection, opportunistic infections); when applied to the large surfaces are possible systemic effects (gastritis, “steroid” gastric ulcer, adrenal insufficiency, Cushing’s syndrome, “steroid” diabetes, slowing reparative processes).
special instructions
Apply only short courses in small areas of the skin. During treatment, it is recommended to wear loose-fitting clothing. The drug should not be applied to the face. Avoid getting product in eyes. With the development of local infection is used in combination with antimicrobial drugs.
Effects on ability to drive and engage in other potentially hazardous activities that require high concentration and psychomotor speed reactions No effect.
Storage conditions
At a temperature of not higher than 15 C. Keep out of reach of children.
Dosing and Administration
Outwardly. At pre-mashed swab moistened antiseptic liquid, is applied to the skin a small amount of the drug 2-4 times a day and gently rubbed. If necessary, you can apply an occlusive dressing, leaving it on the affected surface up to 3-4 days. Never use under the bandage over 2 g / day.
The duration of treatment depends on the nature of the disease and the effectiveness of therapy, usually accounting for 5-10 days. When the thrust course of the disease course of treatment may be extended to 25 days or more. In children, it is recommended to use the minimum effective dose, not more than 5 days.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

QUINACRINE INN

There are no reviews yet.

Add your review